Skip to Main Content

Ana Lledo Delgado, MD

Associate Research Scientist
DownloadHi-Res Photo

About

Titles

Associate Research Scientist

Biography

Ana Lledó Delgado graduated in Medicine and Surgery by the University Autónoma of Madrid (Madrid, Spain. 2011-2017). After graduating, she obtained a Master's Degree in Clinical Medicine (University Camilo José Cela, Madrid 2017-2018). Then, she joined the Department of Rheumatology at the Hospital 12 de Octubre, where she completed her residency in rheumatology (2018-2022). She is accredited by the European Alliance of Rheumatology in musculoskeletal ultrasound and in management of rheumatic disease patients.

In addition to her clinical training, Ana holds a Master's degree in Research Methodology in Health Sciences by the University of Salamanca (2018-2019) and Master´s degree in Bioinformatics and Biostatistics by the University of Barcelona-Oberta Cataluña (2022-2025).

After finishing her residency, in July 2022 she joined the Dr. Herold lab at the Immunobiology Department as a Postdoctoral Associate to understand distinct mechanisms that contribute to autoimmune disorders. In 2023, she was promoted to Associate Researcher in recognition of her contributions to lab research. Additionally, Ana collaborates as a bioinformatician with the Yale School of Medicine´s Library and other institutions, combining her knowledge in health science and computational methods.

Education & Training

MSc
University Oberta of Catalonia and Barcelona, Bioinformatics and Biostatistics (2025)
Residency
University Hospital 12 de Octubre (2022)
MSc
University of Salamanca, Research Methodology in Health Sciences (2019)
MSc
University Camilo José Cela, Clinical Medicine (2018)
MD
University Autónoma de Madrid, Medicine and Surgery

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Ana Lledo Delgado's published research.

Publications

2024

2023

2022

2021

2020

Academic Achievements & Community Involvement

  • activity

    Effects of Latent EBV on Responses to anti-cd3 Mab (teplizumab) in Type 1 Diabetes

  • honor

    Travel award for oral communication presenters at FOCIS 2023 Boston

  • honor

    SORCOM short-stay mobility award for residents performing research in centers of international excellence

  • honor

    European Alliance of Associations for Rheumatology (EULAR) Certified Rheumatologist

  • honor

    Best oral communication prize at the International Congress of Oncology for Students

Get In Touch